General Information of Drug (ID: DMJD1TN)

Drug Name
VE303
Indication
Disease Entry ICD 11 Status REF
Clostridium infection 1A04 Phase 2 [1]
Drug Type
Live biotherapeutic product
Cross-matching ID
TTD ID
DJ81QF

References

1 ClinicalTrials.gov (NCT03788434) Phase 2 Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection (CONSORTIUM). U.S. National Institutes of Health.